Cigna earnings beat by $0.04, revenue topped estimates
In a turbulent market environment, B&G Foods Holdings Corp (NYSE:BGS) stock has touched a 52-week low, sinking to $4.05. The company, known for its diverse portfolio of food brands, has faced significant headwinds over the past year, reflected in a stark 1-year change with a decline of -57.28%. Investors have shown concern as the stock plummeted to this new low, marking a challenging phase for the food producer amidst shifting consumer trends and operational pressures. The 52-week low serves as a critical indicator of the current sentiment surrounding the stock, as B&G Foods grapples with the factors contributing to its recent performance dip.
In other recent news, B&G Foods Inc. reported its Q1 2025 financial results, revealing earnings per share of $0.04, which fell short of the expected $0.16. The company also missed revenue estimates, posting net sales of $425.4 million against a forecasted $459.33 million. This earnings miss highlights a challenging start to the year for B&G Foods, with net sales declining 10.5% year-over-year. Additionally, the company has adjusted its full-year 2025 net sales guidance to between $1.86 billion and $1.91 billion, and its EBITDA guidance to a range of $280 million to $290 million. In other developments, B&G Foods held its annual stockholder meeting, where ten directors were elected, executive compensation was approved, and KPMG LLP was ratified as the independent auditor. These recent developments are pivotal for investors tracking B&G Foods’ performance and strategic direction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.